Literature DB >> 12807905

Nanoparticles of compacted DNA transfect postmitotic cells.

Ge Liu1, DeShan Li, Murali K Pasumarthy, Tomasz H Kowalczyk, Christopher R Gedeon, Susannah L Hyatt, Jennifer M Payne, Timothy J Miller, Peter Brunovskis, Tamara L Fink, Osman Muhammad, Robert C Moen, Richard W Hanson, Mark J Cooper.   

Abstract

Charge-neutral DNA nanoparticles have been developed in which single molecules of DNA are compacted to their minimal possible size. We speculated that the small size of these DNA nanoparticles may facilitate gene transfer in postmitotic cells, permitting nuclear uptake across the 25-nm nuclear membrane pore. To determine whether DNA nanoparticles can transfect nondividing cells, growth-arrested neuroblastoma and hepatoma cells were transfected with DNA/liposome mixtures encoding luciferase. In both models, growth-arrested cells were robustly transfected by compacted DNA (6,900-360-fold more than naked DNA). To evaluate mechanisms responsible for enhanced transfection, HuH-7 cells were microinjected with naked or compacted plasmids encoding enhanced green fluorescent protein. Cytoplasmic microinjection of DNA nanoparticles generated a approximately 10-fold improvement in transgene expression as compared with naked DNA; this enhancement was reversed by the nuclear pore inhibitor, wheat germ agglutinin. To determine the upper size limit for gene transfer, DNA nanoparticles of various sizes were microinjected into the cytoplasm. A marked decrease in transgene expression was observed as the minor ellipsoidal diameter approached 25 nm. In summary, suitably sized DNA nanoparticles productively transfect growth arrested cells by traversing the nuclear membrane pore.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12807905     DOI: 10.1074/jbc.M305776200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  Non-degradative intracellular trafficking of highly compacted polymeric DNA nanoparticles.

Authors:  Anthony J Kim; Nicholas J Boylan; Jung Soo Suk; Samuel K Lai; Justin Hanes
Journal:  J Control Release       Date:  2011-10-30       Impact factor: 9.776

Review 3.  Gene therapy in clinical medicine.

Authors:  S M Selkirk
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

4.  Reducible DNA nanoparticles enhance in vitro gene transfer via an extracellular mechanism.

Authors:  Wenchao Sun; Pamela B Davis
Journal:  J Control Release       Date:  2010-05-12       Impact factor: 9.776

5.  Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor.

Authors:  A M Fletcher; T H Kowalczyk; L Padegimas; M J Cooper; D M Yurek
Journal:  Neuroscience       Date:  2011-08-04       Impact factor: 3.590

6.  Optimization of hCFTR lung expression in mice using DNA nanoparticles.

Authors:  Linas Padegimas; Tomasz H Kowalczyk; Sam Adams; Chris R Gedeon; Sharon M Oette; Karla Dines; Susannah L Hyatt; Ozge Sesenoglu-Laird; Olena Tyr; Robert C Moen; Mark J Cooper
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

7.  DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma.

Authors:  Adriana L da Silva; Sabrina V Martini; Soraia C Abreu; Cynthia dos S Samary; Bruno L Diaz; Sandra Fernezlian; Vanessa Karen de Sá; Vera Luiza Capelozzi; Nicholas J Boylan; Rodolfo Gustavo Goya; Jung Soo Suk; Patricia R M Rocco; Justin Hanes; Marcelo M Morales
Journal:  J Control Release       Date:  2014-02-17       Impact factor: 9.776

8.  Novel pentablock copolymers for selective gene delivery to cancer cells.

Authors:  Bingqi Zhang; Mathumai Kanapathipillai; Paul Bisso; Surya Mallapragada
Journal:  Pharm Res       Date:  2009-01-14       Impact factor: 4.200

Review 9.  Barriers for retinal gene therapy: separating fact from fiction.

Authors:  Rajendra Kumar-Singh
Journal:  Vision Res       Date:  2008-06-18       Impact factor: 1.886

Review 10.  Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies.

Authors:  James L Kreindler
Journal:  Pharmacol Ther       Date:  2009-11-10       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.